Kardia Leung | People | Arnold & Porter

Kardia Leung advises on a broad range of corporate, finance and commercial transactions, including mergers and acquisitions (both domestic and cross-border), debt financing, debt capital markets, secondary transactions, joint ventures, restructurings and fundraisings, as well as general corporate advisory work. Ms. Leung has represented a variety of clients which include sovereign states, financial institutions, real estate investors, and some of the world's most sophisticated biotechnology and pharmaceutical companies.

Ms. Leung also advises charitable organisations on a wide range of pro bono matters, including one which was shortlisted for the Legal Week Innovation Awards 2020 in the "Corporate Social Responsibility Innovation (Multi-Firm)" category.

Ms. Leung is passionate about promoting social mobility within the legal profession and is involved in leading Arnold & Porter’s Accelerate Work Experience Scheme as well as mentoring students through the Social Mobility Business Partnership and 10,000 Black Interns programme.

Focus Areas

Experience

USI Inc. on the sale of its broking business, Oxford Insurance Group, to The Ardonagh Group.
Omega Healthcare Investors, Inc. on a number of high-value transactions concerning its acquisition and lease of healthcare facilities across the UK and Jersey and general corporate advisory work.
Mark G. Anderson Consultants Inc. on its acquisition of London-based property and construction consultants Robinson Low Francis LLP.
Better HoldCo Inc., a U.S.-based digital homeownership platform, in its acquisition of the UK-based digital mortgage and insurance broker Trussle.

Omega Healthcare Investors, Inc. on its acquisition of the remaining 51% equity interest in its JV with Cindat.
Omega Healthcare Investors, Inc. on its restructuring to a UK REIT to hold its UK portfolio of assets.

Amicus Therapeutics, Inc. on its $430 million financing collaboration with Blackstone.
Amicus Therapeutics, Inc. on its $400 million debt financing with Hayfin Capital Management.
The Lenders on the restructuring of Cineworld Group plc’s $9 billion debt.

Hungary on its offer and sale of U.S.$500,000,000 of its 6.125% Notes due 2028.
Hungary on its tap issue of (i) U.S.$150,000,000 6.125% Notes due 2028 and (ii) $300,000,000 6.250% Notes due 2032.
Hungary on its $2.25 billion Notes due 2031, $2 billion Notes due 2051 and €1 billion notes due 2028.
The Republic of Türkiye on an offering of US$2.5 billion of its green bonds.
The Republic of Azerbaijan on its $1.25 billion debut international bond offering.

Pfizer Inc. in relation to (i) its supply agreements with governmental authorities concerning the roll-out of Pfizer and BioNTech’s mRNA-based vaccine, Corminaty^® BNT162b2, against SARS-CoV-2, and (ii) its global vaccines donations regime.
Pfizer Ltd on its collaboration agreement with Entia Limited to develop a home blood monitoring system, Affinity™, for breast cancer patients.
Norgine B.V. on its exclusive licence and distribution agreement for PLENVU® in China with Beijing Podconley Pharmaceutical Technology & Development Co., Ltd., a Chinese pharmaceutical company.